Total Clarity Wealth Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Total Clarity Wealth Management’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9	Closed	-$9K	–	1077
2021 Q3	$9K	Buy	+9	New	+$11.3K	﹤0.01%	721
2021 Q2	–	Sell	-2	Closed	-$5K	–	803
2021 Q1	$5K	Buy	+2	New	+$3.96K	﹤0.01%	709
2020 Q4	–	Sell	-27	Closed	-$74K	–	154
2020 Q3	$74K	Sell	27 -3	-10%	-$7.48K	0.06%	125
2020 Q2	$84K	Buy	30 +1	+3%	+$3.23K	0.08%	125
2020 Q1	$76K	Buy	29 +13	+81%	+$38.8K	0.12%	96
2019 Q4	$42K	Buy	+16	New	+$20.8K	0.03%	291

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Total Clarity Wealth Management's APTO Position: Q4 2021 in Review

Total Clarity Wealth Management sold out of Aptose Biosciences, Inc. (APTO) in Q4 2021, closing a stake of 9 shares — an estimated $9K sold.

Total Clarity Wealth Management first reported a position in APTO in Q4 2019 and held it in 6 quarters. The position peaked at $84K in Q2 2020. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.

Total Clarity Wealth Management reported no remaining Aptose Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
Total Clarity Wealth Management sold 9 Aptose Biosciences, Inc. shares in Q4 2021, an estimated $9K.
Total Clarity Wealth Management first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 6 quarters.
Total Clarity Wealth Management's Aptose Biosciences, Inc. position peaked at $84K in Q2 2020.
58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2021.

Based on Total Clarity Wealth Management's 13F filing for Q4 2021, filed 3 Feb 2022.